August 12, 2024 C-Path Welcomes CuraSen As Newest CPP Member C-Path is thrilled to welcome CuraSen Therapeutics as the newest member of its Critical Path for Parkinson’s Consortium.
August 8, 2024 C-Path’s TRxA Announces $250,000 Award for Drug Development Project in ALS C-Path)'sTranslational Therapeutics Accelerator (TRxA) announced today a new research grant awarded...
August 6, 2024 C-Path Welcomes New Advisory Members to Alpha-1 Antitrypsin Deficiency Consortium C-Path's Critical Path for Alpha-1 Antitrypsin Deficiency (CPA-1) consortium today announced the addition of several...
August 1, 2024 Advancing Rare Disease Measurement With The Rare Disease COA Resource It is estimated that more than 350 million people worldwide live with a rare disease.
July 31, 2024 Meet the Team — Q&A with Clinical Outcome Assessment Scientist Cole Ayasse I am a Clinical Outcome Assessment (COA) Scientist in the COA Program at C-Path.
July 29, 2024 A Modern Curriculum for Training Scientists in Model-Informed Drug Development: Progress Report on FDA Grant to Train Regulatory Scientists C-Path and experienced private sector partners collaborated with global health organizations to create didactic video materials...
July 28, 2024-August 1, 2024 Join C-Path at AAIC 2024 Be sure to come by and join the C-Path team at the Alzheimer’s Association International Conference (AAIC) 2024!
July 26, 2024 C-Path’s Alzheimer’s Consortium Unveils Seminal Methodology to Enhance Alzheimer’s Clinical Trials Using Imaging Biomarkers C-Path is proud to announce the publication of a new study in the journal Alzheimer’s & Dementia...
July 23, 2024 C-Path’s Lysosomal Disease Consortium Welcomes Chiesi Group as its Newest Member C-Path's Critical Path for Lysosomal Diseases (CPLD) Consortium today proudly announced the addition of Chiesi Group...
July 23, 2024 DATAcc by DiMe Expands Library of Digital Measurement Products to Include Parkinson’s Disease Today, the Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe), in partnership....
